Treatment with Oral Active Vitamin D Is Associated with Decreased Risk of Peritonitis and Improved Survival in Patients on Peritoneal Dialysis.

MLA

Kerschbaum, Julia, et al. “Treatment with Oral Active Vitamin D Is Associated with Decreased Risk of Peritonitis and Improved Survival in Patients on Peritoneal Dialysis.” PLoS ONE, vol. 8, no. 7, July 2013, pp. 1–8. EBSCOhost, https://doi.org/10.1371/journal.pone.0067836.

APA

Kerschbaum, J., Vychytil, A., Lhotta, K., Prischl, F. C., Wiesholzer, M., Machhold-Fabrizii, V., Kopriva-Altfahrt, G., Schwarz, C., Balcke, P., Oberbauer, R., Kramar, R., König, P., & Rudnicki, M. (2013). Treatment with Oral Active Vitamin D Is Associated with Decreased Risk of Peritonitis and Improved Survival in Patients on Peritoneal Dialysis. PLoS ONE, 8(7), 1–8. https://doi.org/10.1371/journal.pone.0067836

Chicago

Kerschbaum, Julia, Andreas Vychytil, Karl Lhotta, Friedrich C. Prischl, Martin Wiesholzer, Veronika Machhold-Fabrizii, Gertrude Kopriva-Altfahrt, et al. 2013. “Treatment with Oral Active Vitamin D Is Associated with Decreased Risk of Peritonitis and Improved Survival in Patients on Peritoneal Dialysis.” PLoS ONE 8 (7): 1–8. doi:10.1371/journal.pone.0067836.